Glen Eagle Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-386
Closed -$9.18K – 1074
2025
Q1
$9.18K Buy
386
+2
+0.5% +$47 ﹤0.01% 653
2024
Q4
$9.01K Buy
384
+6
+2% +$142 ﹤0.01% 671
2024
Q3
$9.11K Buy
378
+4
+1% +$95 ﹤0.01% 673
2024
Q2
$8.73K Buy
374
+3
+0.8% +$70 ﹤0.01% 674
2024
Q1
$8.7K Buy
371
+304
+454% +$7.15K ﹤0.01% 681
2023
Q4
$1.58K Buy
67
+1
+2% +$23 ﹤0.01% 890
2023
Q3
$1.49K Hold
66
– – ﹤0.01% 895
2023
Q2
$1.51K Buy
66
+1
+2% +$23 ﹤0.01% 903
2023
Q1
$1.52K Hold
65
– – ﹤0.01% 898
2022
Q4
$1.49K Buy
65
+1
+2% +$23 ﹤0.01% 947
2022
Q3
$1.45K Hold
64
– – ﹤0.01% 924
2022
Q2
$1.49K Buy
64
+18
+39% +$427 ﹤0.01% 863
2022
Q1
$1.11K Hold
46
– – ﹤0.01% 866
2021
Q4
$1.17K Buy
46
+1
+2% +$26 ﹤0.01% 856
2021
Q3
$1.18K Hold
45
– – ﹤0.01% 979
2021
Q2
$1.19K Hold
45
– – ﹤0.01% 963
2021
Q1
$1.17K Buy
+45
New +$1.18K ﹤0.01% 930

Other funds holding IBD

Glen Eagle Advisors's IBD Position: Q2 2025 in Review

Glen Eagle Advisors sold out of Inspire Corporate Bond ETF (IBD) in Q2 2025, closing a stake of 386 shares — an estimated $9.18K sold.

Glen Eagle Advisors first reported a position in IBD in Q1 2021 and held it in 17 quarters. The position peaked at $9.18K in Q1 2025. 94 funds tracked by Wall St. Rank hold IBD as of Q2 2025.

  • Glen Eagle Advisors reported no remaining Inspire Corporate Bond ETF position as of Q2 2025 after selling out during the quarter.
  • Glen Eagle Advisors sold 386 Inspire Corporate Bond ETF shares in Q2 2025, an estimated $9.18K.
  • Glen Eagle Advisors first reported a position in Inspire Corporate Bond ETF in Q1 2021 and held it in 17 quarters.
  • Glen Eagle Advisors's Inspire Corporate Bond ETF position peaked at $9.18K in Q1 2025.
  • 94 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2025.

Based on Glen Eagle Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.